Harvard Bioscience, Inc. ( HBIO) - Stock Earnings
HBIO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
HBIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.8 million USD | 23.7 million USD |
| 2026Q1 | -3.4 million USD | 20.8 million USD |
| 2026Q2 | -2.9 million USD | 22.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
HBIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -3.4 million USD | 112.3 million USD |
| 2024 | -12.4 million USD | 94.1 million USD |
| 2025 | -56.7 million USD | 86.6 million USD |
| 2026 Est. | — | — |
HBIO
Price: $8.09
Earnings Per Share: -2.23 USD
Exchange: NGM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 13674
Ebitda: 836000Market Capitalization: 38.6 million